» Articles » PMID: 23093629

Challenging the 10-year Rule: The Accuracy of Patient Life Expectancy Predictions by Physicians in Relation to Prostate Cancer Management

Overview
Specialty Urology
Date 2012 Oct 25
PMID 23093629
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: : We assess physicians' ability to accurately predict life expectancies. In prostate cancer this prediction is especially important as it affects screening decisions. No previous studies have examined accuracy in the context of real cases and concrete end points.

Methods: : Seven clinical scenarios were summarized from charts of deceased patients. We recruited 100 medical professionals to review these scenarios and estimate each patient's life expectancy. Responses were analyzed with respect to the patients' actual survival end points, then stratified based on the demographic information provided.

Results: : Respondent factors, such as sex, level of training, location of work or specialty, made no significant difference on prediction accuracy. Furthermore, respondents were typically pessimistic in their estimations with a negative linear trend between estimated life expectancy and actual survival. Overall, respondents were within 1 year of actual life expectancy only 15.9% of the time; on average, respondents were 67.4% inaccurate in relation to actual survival. If framed in terms of correctly identifying which patients would live more than or less than 10 years (dichotomous accuracy), physicians were correct 68.3% of the time.

Conclusions: : Physicians do poorly at predicting life expectancy and tend to underestimate how long patients have left to live. This overall inaccuracy raises the question of whether physicians should refine screening and treatment criteria, find a better proxy or dispose of the criteria altogether.

Citing Articles

Tackling Guideline Non-concordance: Primary Care Barriers to Incorporating Life Expectancy into Lung Cancer Screening Decision-Making-A Qualitative Study.

Kearney L, Bolton R, Nunez E, Boudreau J, Sliwinski S, Herbst A J Gen Intern Med. 2024; 39(12):2284-2291.

PMID: 38459413 PMC: 11347517. DOI: 10.1007/s11606-024-08705-x.


Inappropriate Determinations of Inappropriateness for Lung Cancer Screening.

Gould M Am J Respir Crit Care Med. 2023; 209(2):130-131.

PMID: 38051108 PMC: 10806416. DOI: 10.1164/rccm.202310-1858ED.


Development and validation of a life expectancy calculator for US patients with prostate cancer.

Chase E, Bryant A, Sun Y, Jackson W, Spratt D, Dess R BJU Int. 2022; 130(4):496-506.

PMID: 35373440 PMC: 9474626. DOI: 10.1111/bju.15740.


Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration.

Soerensen S, Thomas I, Schmidt B, Daskivich T, Skolarus T, Jackson C Urology. 2021; 155:70-76.

PMID: 34139251 PMC: 8429253. DOI: 10.1016/j.urology.2021.05.056.


Urological outcomes in nonagenarians with prostate cancer.

White J, Ory J, Morris H, Rendon R, Mason R, Cox A Can Urol Assoc J. 2021; 15(8):E393-E396.

PMID: 33410737 PMC: 8418258. DOI: 10.5489/cuaj.6805.


References
1.
Andriole G, Crawford E, Grubb 3rd R, Buys S, Chia D, Church T . Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310-9. PMC: 2944770. DOI: 10.1056/NEJMoa0810696. View

2.
Schroder F, Hugosson J, Roobol M, Tammela T, Ciatto S, Nelen V . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320-8. DOI: 10.1056/NEJMoa0810084. View

3.
Henderson R, Keiding N . Individual survival time prediction using statistical models. J Med Ethics. 2005; 31(12):703-6. PMC: 1734073. DOI: 10.1136/jme.2005.012427. View

4.
Ellison L, De P, Mery L, Grundy P . Canadian cancer statistics at a glance: cancer in children. CMAJ. 2009; 180(4):422-4. PMC: 2638027. DOI: 10.1503/cmaj.081155. View

5.
Walz J, Gallina A, Perrotte P, Jeldres C, Trinh Q, Hutterer G . Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int. 2007; 100(6):1254-8. DOI: 10.1111/j.1464-410X.2007.07130.x. View